PrEP4All

PrEP4All We're fighting for a National PrEP Program to deliver universal access to HIV-prevention medication. Together, let's finally end the HIV epidemic.

We fight to ensure that the most vulnerable individuals can access HIV and other critical preventive care and treatment regardless of their race, gender, socioeconomic status, or geographic location.

Maxx Boykin, Save HIV Funding Campaign Manager, facilitating a discussion on “Building Black and Brown Unity” for Latino...
09/02/2026

Maxx Boykin, Save HIV Funding Campaign Manager, facilitating a discussion on “Building Black and Brown Unity” for Latinos in the South’s Atlanta Health Solidarity Lunch & Learn.

Join the Save HIV Funding Campaign, USPLWH Caucus, and The SERO Project for our Using Your Story: Pre-Obituary Training,...
08/27/2026

Join the Save HIV Funding Campaign, USPLWH Caucus, and The SERO Project for our Using Your Story: Pre-Obituary Training, as we talk about the power of storytelling and creative writing.

Date: September 3, 2026
Time: 4PM ET/1PM PT
Register: bit.ly/shf-using-your-story

Today is Southern HIV/AIDS Awareness Day. With funding cuts threatening the HIV response in Southern states, the Save HI...
08/20/2026

Today is Southern HIV/AIDS Awareness Day. With funding cuts threatening the HIV response in Southern states, the Save HIV Funding Campaign highlights ways you can take action. Swipe left to find out how to get involved.

08/12/2026

A conservative group wants TV Land to stop airing a awareness campaign Michelle Visage. prevention advocates are urging Paramount Global to keep the ads on the air and continue to make accurate HIV prevention information visible.
positivelyaware.com/paramount-petition

PrEP Users and advocates thank Paramount and TV Land for standing for PrEP education and airing the PrEP Wisdom campaign...
08/10/2026

PrEP Users and advocates thank Paramount and TV Land for standing for PrEP education and airing the PrEP Wisdom campaign featuring Michelle Visage.

One Million Moms, a projected of the anti-LGBTQ American Family Association, is demanding the removal of the campaign. Show that you support access to PrEP education and stand against LGBTQ hate by signing the petition at bit.ly/p4a-standup-petition.

Continue to support the work of PrEP advocates by making a one time or recurring donation at prep4all.org/donate/2025.

08/04/2026

The California Supreme Court sided with Gilead Sciences in a closely watched case over whether the company had a "duty" to innovate.

Behind the Scenes of an upcoming collaboration between PrEP4All and TiYM Network with support from The Counter  Narrativ...
08/01/2026

Behind the Scenes of an upcoming collaboration between PrEP4All and TiYM Network with support from The Counter Narrative Project about access to PrEP and HIV care.

Stay Tuned!

From our partners at Advocates for Youth: Tell Congress to Protect CDC HIV Prevention Funding
07/29/2026

From our partners at Advocates for Youth:
Tell Congress to Protect CDC HIV Prevention Funding

Nearly 100 community based organizations across the country receive CDC funding to provide HIV prevention to communities most disproportionately affected by HIV. Recently, those organizations learned that the CDC will no longer fund a program that provides HIV prevention including testing, community...

Join the Save HIV Funding Campaign for our Civic Engagement Training, Part II, where we will discuss how we engage candi...
07/27/2026

Join the Save HIV Funding Campaign for our Civic Engagement Training, Part II, where we will discuss how we engage candidates during an election year - as organizations and as individuals. We will discuss candidate forums, town halls, canvassing, and direct voter engagement during this expert-led presentation.

Register at bit.ly/shf-civic-engagement-2

Since 2018, PrEP4All has called for vital HIV prevention pills to be priced at a level based upon manufacturing cost plu...
07/24/2026

Since 2018, PrEP4All has called for vital HIV prevention pills to be priced at a level based upon manufacturing cost plus a reasonable profit. Should the Federal Drug Administration (FDA) approve alimatravir next year following the completion of phase 3 trials, we are eager to see if the company’s commitment to access will lead to pricing that makes this exciting innovation available to publicly funded public health systems in countries not included in the announcement, including Mexico, Brazil, and the United States.

For media inquiries, contact Michael Chancley, Communications and Mobilization Manager at [email protected]. NEW YORK, NEW YORK – FRIDAY, JULY 24, 2026 – PrEP4All…

Address

New York, NY

Alerts

Be the first to know and let us send you an email when PrEP4All posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share